mimiX Biotherapeutics Ltd.

mimiX is a biomedical company based in Switzerland. Our proprietary tissue production technology – Sound Induced Morphogenesis – was developed as a result of 10+ years of research and development efforts.

Our lead product in development is in the area of personalized medicine – FastSkin®, an autologous tissue for complex wound care. Future areas of interest include: regenerative medicine (neuroscience, cardiovascular, orthopaedics), drug development, cellular agriculture (clean meat), process technology and performance materials.

We target strategic discovery partnerships through industry and academic alliances.